These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30319275)

  • 1. Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
    Cao X; He GZ
    Onco Targets Ther; 2018; 11():6351-6360. PubMed ID: 30319275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of PTPN18 for regulating the migration and invasion of endometrial cancer cells via the MYC/PI3K/AKT pathway.
    Suo S; Chen S; Zhou L; Xu R; Li J; Li W
    Histol Histopathol; 2024 May; ():18767. PubMed ID: 38855855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway.
    Sun R; Sun X; Liu H; Li P
    Onco Targets Ther; 2019; 12():10863-10872. PubMed ID: 31849490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat Shock Protein B7 Inhibits the Progression of Endometrial Carcinoma by Inhibiting PI3K/AKT/mTOR Pathway.
    Xing M; Wu B; Wang S
    Reprod Sci; 2023 Feb; 30(2):590-600. PubMed ID: 35859224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
    Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M
    Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma.
    Huang L; Zhao C; Sun K; Yang D; Yan L; Luo D; He J; Hu X; Wang R; Shen X; Xiao N; Zhong Z
    Cell Biochem Funct; 2020 Jul; 38(5):541-548. PubMed ID: 32056244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of integrin α7 on cell proliferation, invasion, apoptosis and the PI3K/AKT pathway, and its association with clinicopathological features in endometrial cancer.
    Liang M; Liu C; Lei T; Guo S; Min J
    Oncol Lett; 2023 Jan; 25(1):26. PubMed ID: 36478908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
    Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA/RAC1 pathway-associated markers.
    Wang JS; Ruan F; Guo LZ; Wang FG; Wang FL; An HM
    Genes Genomics; 2021 May; 43(5):447-457. PubMed ID: 33683574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TUG1 promotes the migration and invasion in type I endometrial carcinoma cells by regulating E-N cadherin switch.
    Chen Q; Schatz C; Cen Y; Chen X; Haybaeck J; Li B
    Taiwan J Obstet Gynecol; 2022 Sep; 61(5):780-787. PubMed ID: 36088044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    Lin L; Gao Y; Hu X; Ouyang J; Liu C
    BMC Womens Health; 2022 Nov; 22(1):470. PubMed ID: 36434592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
    Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
    Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway.
    Liu Y; Chang Y; He X; Cai Y; Jiang H; Jia R; Leng J
    Front Oncol; 2020; 10():1525. PubMed ID: 32984001
    [No Abstract]   [Full Text] [Related]  

  • 17. Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α.
    Kojima M; Sugimoto K; Kobayashi M; Ichikawa-Tomikawa N; Kashiwagi K; Watanabe T; Soeda S; Fujimori K; Chiba H
    Mol Cancer Res; 2021 Jul; 19(7):1208-1220. PubMed ID: 33727343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTUB2 promotes the progression of endometrial cancer by regulating the PKM2-mediated PI3K/AKT signaling pathway.
    Zhang Q; Zhang J; Yao A; Tian X; Han Z; Yuan Y; Tao K; Yang X
    Cell Biol Int; 2023 Feb; 47(2):428-438. PubMed ID: 36316812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.
    Qu J; Sun Y; Yang L; Niu X; Li L
    J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CDK9 in endometrial cancer tissues and its effect on the proliferation of HEC-1B.
    Yang W; Liu S; Luo Q; Tan X
    Open Life Sci; 2021; 16(1):1341-1346. PubMed ID: 35071768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.